You can buy or sell Avinger and other stocks, options, ETFs, and crypto commission-free!
Avinger, Inc. Common Stock, also called Avinger, is a commercial-stage medical device company. Read More The firm designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Ocelot MVRX, Ocelot PIXL, Pantheris, Wildcat, Juicebox and Kittycat 2. It offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.
Redwood City, California
52 Week High
52 Week Low
Seeking AlphaMar 7
Avinger files for $50M mixed shelf offering; shares down 2% after hours
Avinger (NASDAQ:AVGR) has filed a prospectus for a $50M mixed shelf offering. Shares are down 2% after hours....
Seeking AlphaMar 6
Avinger (AVGR) CEO Jeff Soinski on Q4 2018 Results - Earnings Call Transcript
Avinger (NASDAQ:AVGR) Q4 2018 Earnings Conference Call March 6, 2019 4:30 PM ET Company Participants Matt Kreps - IR Jeff Soinski - CEO Mark Weinswig - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Greetings and welcome to Avinger’s 2018 Fourth Quarter and Full Year Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. [Operato...
Yahoo FinanceMar 6
Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update
Pantheris Fourth Quarter Revenue Increases 18% Over Prior Quarter REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today reported results for the fourth quarter and full year ended December 31, 2018. Fourth Quarter and Recent Highlights Achieved revenue of $2.0 million for the ...
Expected May 13, After Hours